YQZ-82317-15774 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-08
Dose 1 — Pfizer-BioNTech
2021-03-10
Registered in v-safe
2021-03-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains

Adult check-in
2021-03-12
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Joint pains

Adult check-in
2021-03-17
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-03-22
Survey response — day 14, dose 1
MedDRA: Vaginal haemorrhage — Feeling: Good

Free text: I've been having an unusual amount of vaginal bleeding since I got the vaccine, and I think it could be related because women I know are also describing that experience with the vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-29
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-03-30
Dose 2 — Pfizer-BioNTech
2021-03-30
Survey response — day 0, dose 2
MedDRA: Dizziness — Feeling: Fair · Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-31
Survey response — days 1–6 daily, dose 2
MedDRA: Vaginal haemorrhage — Feeling: Fair · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: still having vaginal bleeding that may or may not be IUD related

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-01
Survey response — days 1–6 daily, dose 2
MedDRA: Vaginal haemorrhage — Feeling: Good · Joint pains

Free text: Unusual vaginal bleeding

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-02
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains

Adult check-in
2021-04-03
Survey response — days 1–6 daily, dose 2
MedDRA: Vaginal haemorrhage — Feeling: Fair · Joint pains · Be unable to do your normal daily activities

Free text: still having unusual vaginal bleeding (but might be IUD-related)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains, Fatigue or tiredness

Adult check-in
2021-04-05
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Joint pains

Adult check-in
2021-05-04
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-06-30
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-10-04
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2021-10-04
Health check-in — day 0, dose 3
Feeling: Good · None

Adult check-in
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Redness · Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-10-06
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Itching · None

Adult check-in
2021-10-08
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-28
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-17
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2022-01-03
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-04-06
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-10-04
Survey response — 12 months, dose 3
MedDRA: Antinuclear antibody increased, Arthralgia, Rheumatoid factor positive — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Joint pain, ANA titer 1:80, positive rheumatoid factor.

MedDRA releases: 2024-11 · check-in free text available
2022-10-04
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-10-05
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-08	Pfizer-BioNTech
2	2021-03-30	Pfizer-BioNTech
3	2021-10-04	Pfizer-BioNTech	Flu

Call center

Reported	Outcome	VAERS-related outcome
2022-10-04	Unsuccessful

Free text

Release 6 — day 14, dose 1

2021-03-22

Symptoms: I've been having an unusual amount of vaginal bleeding since I got the vaccine, and I think it could be related because women I know are also describing that experience with the vaccine.

Release 6 — day 0, dose 2

2021-03-30

Systemic reaction (other): Dizziness

Release 6 — days 1–6 daily, dose 2

2021-03-31

Systemic reaction (other): still having vaginal bleeding that may or may not be IUD related

2021-04-01

Systemic reaction (other): Unusual vaginal bleeding

2021-04-03

Systemic reaction (other): still having unusual vaginal bleeding (but might be IUD-related)

Release 12 — 12 months, dose 3

2022-10-04

Symptoms: Joint pain, ANA titer 1:80, positive rheumatoid factor.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Antinuclear antibody increased	·	·	✓
SD	Arthralgia	·	·	✓
SD	Rheumatoid factor positive	·	·	✓
SD	Vaginal haemorrhage	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Vaginal haemorrhage	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release